Introduction: Subclavian artery stenosis is most commonly caused by atherosclerotic disease. Surgical treatment is associated with high morbidity and mortality. Intervention is generally reserved for the management of symptomatic patients who present with upper limb ischemia, Vertebrobasilar symptoms and subclavian steal syndrome. Endovascular stenting is preferred over surgery because of high success rate, less invasive and minimal complications.
INTRODUCTION
Subclavian artery stenosis is most commonly caused by atherosclerotic disease. Stenosis typically occurs in the first part of the subclavian artery proximal to the origin of the vertebral artery extending from the ostium to the origin of the vertebral artery. The incidence of left subclavian artery stenosis is far higher than that of right subclavian artery stenosis.
Intervention is generally reserved for the management of symptomatic patients who present with upper limb ischemia, Vertebrobasilar symptoms and subclavian steal syndrome. Endovascular stenting is preferred over surgery because of high success rate, less invasive and minimal complications. Here we report a case of 56 year old female patient presented with subclavian steal syndrome whom we successfully treated with percutaneous transluminal angioplasty (PTA).
CASE REPORT
A 56 year old female patient with history of hypertension and diabetes presented with dizziness, vertigo and left arm claudication with use of her left upper extremity since last six months.
On physical examination
Inability to measure BP on left arm with absent left radial pulse and right upper limb BP was 160/80 mmHg. There were no signs of ischemia in left upper extremity.
Investigations
Electrocardiogram showed sinus rhythm with no ST-T changes, Transthoracic echocardiography revealed good biventricular function with type 1 diastolic dysfunction. Coronary angiography showed mild single vessel disease. Aortic arch angiography and selective left subclavian angiography revealed total occlusion of left ostio-proximal subclavian artery (Figure 1 ).
Procedure
The procedure was performed under local anaesthesia. The right femoral artery and left brachial artery were accessed percutaneously with 8 F and 6 F introducer sheaths, respectively. A preprocedural loading dose of Aspirin 325 mg and 600mg of clopidogrel was given. Intravenous heparin 100 IU/kg and antibiotic were given.
Ostia of left subclavian artery was engaged by using JR 7 F 
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guiding catheter. Check angio showed total occlusion. A 6 F shuttle sheath was used to cannulate the vessel and placed distal to the occlusion. The lesion was crossed retrogradely using 0.014 × 190 cm cross-it 200 and placed in proximal descending aorta ( Figure 2A ). Lesion was predilated using 3.5 × 15 mm balloon at 8 atm pressure ( Figure 2B ). Check angiogram through JR guiding catheter established good antegrade flow with no dissection ( Figure 2C ). Using another 0.014 × 180 cm BMW wire crossed the lesion antegradely and the cross-it 200 wire removed ( Figure 2D ). An 8 × 32 mm INVATEC scuba stent was deployed across ostioproximal subclavian artery ( Figure 2E ) with a good angiographic result ( Figure 2F ).
Post procedure course was uneventful. The patient was discharged after three days with Aspirin 150 mg OD, Clopidogrel 75 mg BD and Rosuvastatin 40 mg OD.
Follow-up
Patient was followed up at 1, 3, 6 months and one year. Patient reported marked improvement of symptoms. At each visit, patient was monitored with Duplex ultrasound of left subclavian artery, measurement of BP and examination of pulse.
DISCUSSION
Peripheral arterial disease is due to atherosclerotic disease involving the proximal subclavian or innominate arteries. Atherosclerosis is a progressive disease which can progress from stenosis to total occlusion and is the most common cause of subclavian stenosis and, thus, steal syndromes, irrespective of the clinical manifestation [1] [2] [3] . However, other causes include large artery vasculitis, thoracic outlet syndrome, and stenosis after surgical repair of coarctation of aorta or tetralogy of Fallot.
The presence of subclavian stenosis is associated with increased total mortality (hazard ratio, 1.40) and cardiovascular disease mortality (hazard ratio, 1.57) 2 and with an increased risk of cerebrovascular ischemic events related to progressive carotid stenosis and compromised collateral pathways. Thus, subclavian artery stenosis is a cardiovascular risk marker and requires aggressive secondary prevention.
Even asymptomatic subclavian artery stenosis is associated with increased risk of morbidity and mortality related to underlying atherosclerotic disease burden in other vascular beds [2] [3] [4] .
Symptomatic patients with proximal subclavian artery occlusive disease can be successfully treated either surgically or percutaneously [5, [6] [7] [8] [9] [10] [11] [12] . 
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Surgical options, such as carotid-subclavian bypass, are generally reserved for patients who have failed endovascular treatment. Complications are higher when compared to endovascular stenting with intra-operative mortality ranges from 6% to 19% and higher postoperative stroke rates (1.5-2.1%). Endovascular stenting is less invasive with high technical success and excellent long-term patency rates.
First case report of subclavian angioplasty was done by Bachman and Kim in 1980 [13] . After this report, percutaneous intervention of subclavian disease has grown persistently, becoming the mainstay of therapy. Balloon angioplasty and stenting can be performed when stenting is unlikely to compromise the vertebral circulation. Technical success of the percutaneous approach can be achieved in >90%, with 5-year patency rates of 85% [12] . Complications during subclavian artery intervention are stroke (<1%), dissection, access site complications (0-5%) like hematoma formation, thrombosis and pseudoaneurysm formation.
The major long-term risk of subclavian artery intervention is restenosis. Stenting appears to have significantly reduced the rate of restenosis, from 15-20 % with angioplasty to 0-10%. The treatment for restenosis will depend on its etiology. Failure to cover the ostium or inadequate stent expansion may be treated with repeat angioplasty and, sometimes, re-stenting. Alternatively, surgical revascularization using an extrathoracic approach (carotid-subclavian, axillo-axillary) is a reasonable option in a symptomatic patient who is an operative candidate. This is our first case successfully treated by endovascular stenting, the technique of crossing the chronic total occlusion is with catheters and guide wires similar to treating coronary chronic total occlusion. Hardwares and wires used but no new technique used, but we used technique
